Multi-Objective Latent Space Optimization of Generative Molecular Design Models

Read original: arXiv:2203.00526 - Published 7/23/2024 by A N M Nafiz Abeer, Nathan Urban, M Ryan Weil, Francis J. Alexander, Byung-Jun Yoon
Total Score

0

🛠️

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • Molecular design using generative models like variational autoencoders (VAEs) is efficient for exploring high-dimensional molecular space to find molecules with desired properties.
  • The initial model's performance depends on the training data, but its sampling efficiency can be further enhanced through latent space optimization.
  • The paper proposes a multi-objective latent space optimization (LSO) method to improve the performance of generative molecular design (GMD).

Plain English Explanation

The paper discusses a method for designing molecules using generative models, which are a type of artificial intelligence that can create new molecules. These models are efficient at exploring the vast number of possible molecules to find ones with desirable properties, like being effective drugs.

However, the quality of the molecules the model suggests depends on the data it was trained on. The researchers developed a method to further optimize the model's search process to find even better molecules. Their "multi-objective latent space optimization" approach involves repeatedly retraining the model, giving more weight to molecules that have multiple desirable properties.

The researchers show that this method can significantly improve the model's performance at generating molecules that are optimal for multiple target properties simultaneously.

Technical Explanation

The paper proposes a multi-objective latent space optimization (LSO) method to enhance the performance of generative molecular design (GMD). GMD leverages variational autoencoders (VAEs) to explore the high-dimensional molecular space and identify molecules with desired properties.

The key innovation is an iterative weighted retraining approach, where the weights of molecules in the training data are determined by their Pareto efficiency – i.e., how optimal they are across multiple target properties. By repeatedly retraining the model with these weighted samples, the method can significantly improve the model's ability to jointly optimize multiple molecular properties.

The authors demonstrate the effectiveness of their multi-objective GMD LSO method through experiments on several benchmark datasets. They show that it outperforms standard GMD approaches in generating molecules that are optimal for multiple target properties simultaneously.

Critical Analysis

The paper presents a well-designed and rigorous approach to improving generative molecular design. The multi-objective LSO method is a clever way to guide the model towards discovering high-performing molecules, building on the strengths of VAEs.

However, the paper does not fully address the potential limitations of this approach. For example, the method relies on having access to a diverse training dataset with labeled molecular properties. In practice, such comprehensive data may not always be available, which could constrain the model's performance.

Additionally, the paper does not discuss potential issues around the interpretability and trustworthiness of the generated molecules. As these models become more powerful, it will be important to ensure their outputs can be reliably validated and understood by domain experts.

Further research could explore ways to make the multi-objective LSO method more robust to data limitations, as well as develop techniques to improve the transparency and auditability of the generated molecules.

Conclusion

This paper presents a novel multi-objective latent space optimization method that significantly enhances the performance of generative molecular design. By iteratively retraining the model to prioritize molecules with optimal trade-offs across multiple target properties, the approach can discover high-performing compounds more effectively than standard GMD techniques.

The findings have important implications for accelerating drug discovery and the development of other functional molecules. However, future work is needed to address potential limitations around data requirements and model interpretability. Overall, this research represents an important step forward in leveraging AI to navigate the vast space of possible molecules and identify promising candidates for real-world applications.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

🛠️

Total Score

0

Multi-Objective Latent Space Optimization of Generative Molecular Design Models

A N M Nafiz Abeer, Nathan Urban, M Ryan Weil, Francis J. Alexander, Byung-Jun Yoon

Molecular design based on generative models, such as variational autoencoders (VAEs), has become increasingly popular in recent years due to its efficiency for exploring high-dimensional molecular space to identify molecules with desired properties. While the efficacy of the initial model strongly depends on the training data, the sampling efficiency of the model for suggesting novel molecules with enhanced properties can be further enhanced via latent space optimization. In this paper, we propose a multi-objective latent space optimization (LSO) method that can significantly enhance the performance of generative molecular design (GMD). The proposed method adopts an iterative weighted retraining approach, where the respective weights of the molecules in the training data are determined by their Pareto efficiency. We demonstrate that our multi-objective GMD LSO method can significantly improve the performance of GMD for jointly optimizing multiple molecular properties.

Read more

7/23/2024

Leveraging Latent Evolutionary Optimization for Targeted Molecule Generation
Total Score

0

Leveraging Latent Evolutionary Optimization for Targeted Molecule Generation

Siddartha Reddy N, Sai Prakash MV, Varun V, Vishal Vaddina, Saisubramaniam Gopalakrishnan

Lead optimization is a pivotal task in the drug design phase within the drug discovery lifecycle. The primary objective is to refine the lead compound to meet specific molecular properties for progression to the subsequent phase of development. In this work, we present an innovative approach, Latent Evolutionary Optimization for Molecule Generation (LEOMol), a generative modeling framework for the efficient generation of optimized molecules. LEOMol leverages Evolutionary Algorithms, such as Genetic Algorithm and Differential Evolution, to search the latent space of a Variational AutoEncoder (VAE). This search facilitates the identification of the target molecule distribution within the latent space. Our approach consistently demonstrates superior performance compared to previous state-of-the-art models across a range of constrained molecule generation tasks, outperforming existing models in all four sub-tasks related to property targeting. Additionally, we suggest the importance of including toxicity in the evaluation of generative models. Furthermore, an ablation study underscores the improvements that our approach provides over gradient-based latent space optimization methods. This underscores the effectiveness and superiority of LEOMol in addressing the inherent challenges in constrained molecule generation while emphasizing its potential to propel advancements in drug discovery.

Read more

7/22/2024

Integrating Latent Variable and Auto-Regressive Models for Goal-directed Molecule Generation
Total Score

0

Integrating Latent Variable and Auto-Regressive Models for Goal-directed Molecule Generation

Heath Arthur-Loui, Amina Mollaysa, Michael Krauthammer

De novo molecule design has become a highly active research area, advanced significantly through the use of state-of-the-art generative models. Despite these advances, several fundamental questions remain unanswered as the field increasingly focuses on more complex generative models and sophisticated molecular representations as an answer to the challenges of drug design. In this paper, we return to the simplest representation of molecules, and investigate overlooked limitations of classical generative approaches, particularly Variational Autoencoders (VAEs) and auto-regressive models. We propose a hybrid model in the form of a novel regularizer that leverages the strengths of both to improve validity, conditional generation, and style transfer of molecular sequences. Additionally, we provide an in depth discussion of overlooked assumptions of these models' behaviour.

Read more

9/9/2024

🛸

Total Score

0

Latent Chemical Space Searching for Plug-in Multi-objective Molecule Generation

Ningfeng Liu (State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Peking-Tsinghua Center for Life Science), Jie Yu (State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University), Siyu Xiu (State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University), Xinfang Zhao (State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University), Siyu Lin (State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University), Bo Qiang (State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University), Ruqiu Zheng (State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University), Hongwei Jin (State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University), Liangren Zhang (State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University), Zhenming Liu (State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University)

Molecular generation, an essential method for identifying new drug structures, has been supported by advancements in machine learning and computational technology. However, challenges remain in multi-objective generation, model adaptability, and practical application in drug discovery. In this study, we developed a versatile 'plug-in' molecular generation model that incorporates multiple objectives related to target affinity, drug-likeness, and synthesizability, facilitating its application in various drug development contexts. We improved the Particle Swarm Optimization (PSO) in the context of drug discoveries, and identified PSO-ENP as the optimal variant for multi-objective molecular generation and optimization through comparative experiments. The model also incorporates a novel target-ligand affinity predictor, enhancing the model's utility by supporting three-dimensional information and improving synthetic feasibility. Case studies focused on generating and optimizing drug-like big marine natural products were performed, underscoring PSO-ENP's effectiveness and demonstrating its considerable potential for practical drug discovery applications.

Read more

4/11/2024